Brief: Ac Immune Says Informed Enrollment Has Been Temporarily Paused For Phase 2B Retain Trial
17/02/2026 21:49
Feb 17 (Reuters) - AC Immune SA ACIU.O: AC IMMUNE SA: INFORMED BY JANSSEN PHARMACEUTICALS THAT ENROLLMENT HAS BEEN TEMPORARILY PAUSED FOR PHASE 2B RETAIN TRIAL AC IMMUNE SA: TEMPORARY PAUSE IN PHASE 2B RETAIN TRIAL RECRUITMENT IS VOLUNTARY & NOT RELATED TO NEW SAFETY FINDINGS Source text: [ID:n0000950103-26-002195] Further company coverage: ACIU.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on AC Immune SA
See all newsBrief: Ac Immune To Receive Research Grant From Goradia Family For Development Of Aci-7104 In Parkinson’S Disease
AC Immune Q1 net loss narrows on lower expenses
Brief: AC Immune Announces Amendment To Morphomer ® Tau License And Collaboration Agreement With Lilly
U.S. STOCKS ON THE MOVE-Darden Restaurants, Mastercard, Accenture
U.S. STOCKS ON THE MOVE-Darden Restaurants, Mastercard, Accenture